abstract |
Disclosed herein are heterocyclic derivatives of glycinamide of the formula (I) that are inhibitors of the enzyme Lipoprotein Associated Phospholipase (Lp-PLA2) and are of use in therapy, in particular for treating atherosclerosis, wherein the variables shown in formula (I) are as defined in the specification. |